{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T20:21:42Z","timestamp":1776025302317,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T00:00:00Z","timestamp":1470268800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T00:00:00Z","timestamp":1470268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide, and systemic chemotherapy is the major treatment strategy for late-stage HCC patients. Poor prognosis following chemotherapy is the general outcome owing to recurrent resistance. Recent studies have suggested that in addition to cytotoxic effects on tumor cells, chemotherapy can induce an alternative cascade that supports tumor growth and metastasis. In the present investigation, we showed that thyroid hormone (TH), a potent hormone-mediating cellular differentiation and metabolism, acts as an antiapoptosis factor upon challenge of thyroid hormone receptor (TR)-expressing HCC cells with cancer therapy drugs, including cisplatin, doxorubicin and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). TH\/TR signaling promoted chemotherapy resistance through negatively regulating the pro-apoptotic protein, Bim, resulting in doxorubicin-induced metastasis of chemotherapy-resistant HCC cells. Ectopic expression of <jats:italic>Bim<\/jats:italic> in hepatoma cells challenged with chemotherapeutic drugs abolished TH\/TR-triggered apoptosis resistance and metastasis. Furthermore, <jats:italic>Bim<\/jats:italic> expression was directly transactivated by Forkhead box protein O1 (FoxO1), which was negatively regulated by TH\/TR. TH\/TR suppressed FoxO1 activity through both transcriptional downregulation and nuclear exclusion of FoxO1 triggered by Akt-mediated phosphorylation. Ectopic expression of the constitutively active FoxO1 mutant, FoxO1-AAA, but not FoxO1-wt, diminished the suppressive effect of TH\/TR on <jats:italic>Bim<\/jats:italic>. Our findings collectively suggest that expression of <jats:italic>Bim<\/jats:italic> is mediated by FoxO1 and indirectly downregulated by TH\/TR, leading to chemotherapy resistance and doxorubicin-promoted metastasis of hepatoma cells.<\/jats:p>","DOI":"10.1038\/cddis.2016.227","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T12:47:47Z","timestamp":1470314867000},"page":"e2324-e2324","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Chemotherapy resistance and metastasis-promoting effects of thyroid hormone in hepatocarcinoma cells are mediated by suppression of FoxO1 and Bim pathway"],"prefix":"10.1038","volume":"7","author":[{"given":"Hsiang-Cheng","family":"Chi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shen-Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Hung","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu-Kang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Ying","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Ming","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang-Hsiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang-Huei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,4]]},"reference":[{"key":"BFcddis2016227_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/oxfordjournals.epirev.a036102","volume":"15","author":"MC Pike","year":"1993","unstructured":"Pike MC, Spicer DV, Dahmoush L, Press MF . Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993; 15: 17\u201335.","journal-title":"Epidemiol Rev"},{"issue":"Suppl 2","key":"BFcddis2016227_CR2","first-page":"S35","volume":"8","author":"MK Brawer","year":"2006","unstructured":"Brawer MK . Hormonal therapy for prostate cancer. Rev Urol 2006; 8 (Suppl 2): S35\u2013S47.","journal-title":"Rev Urol"},{"key":"BFcddis2016227_CR3","first-page":"325","volume":"31","author":"YH Huang","year":"2008","unstructured":"Huang YH, Tsai MM, Lin KH . Thyroid hormone dependent regulation of target genes and their physiological significance. Chang Gung Med J 2008; 31: 325\u2013334.","journal-title":"Chang Gung Med J"},{"issue":"Pt 1","key":"BFcddis2016227_CR4","first-page":"E715","volume":"258","author":"A Pilo","year":"1990","unstructured":"Pilo A, Iervasi G, Vitek F, Ferdeghini M, Cazzuola F, Bianchi R . Thyroidal and peripheral production of 3,5,3'-triiodothyronine in humans by multicompartmental analysis. Am J Physiol 1990; 258 (Pt 1): E715\u2013E726.","journal-title":"Am J Physiol"},{"key":"BFcddis2016227_CR5","first-page":"325","volume":"31","author":"YH Huang","year":"2008","unstructured":"Huang YH, Tsai MM, Lin KH . Thyroid hormone dependent regulation of target genes and their physiological significance. Chang Gung Med J 2008; 31: 325\u2013334.","journal-title":"Chang Gung Med J"},{"key":"BFcddis2016227_CR6","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.1038\/onc.2009.265","volume":"28","author":"IH Chan","year":"2009","unstructured":"Chan IH, Privalsky ML . Thyroid hormone receptor mutants implicated in human hepatocellular carcinoma display an altered target gene repertoire. Oncogene 2009; 28: 4162\u20134174.","journal-title":"Oncogene"},{"key":"BFcddis2016227_CR7","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","volume":"132","author":"HB El-Serag","year":"2007","unstructured":"El-Serag HB, Rudolph KL . Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557\u20132576.","journal-title":"Gastroenterology"},{"key":"BFcddis2016227_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1046\/j.1365-2265.2003.01697.x","volume":"58","author":"F Sorvillo","year":"2003","unstructured":"Sorvillo F, Mazziotti G, Carbone A, Morisco F, Cioffi M, Rotondi M et al. Increased serum reverse triiodothyronine levels at diagnosis of hepatocellular carcinoma in patients with compensated HCV-related liver cirrhosis. Clin Endocrinol (Oxf) 2003; 58: 207\u2013212.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BFcddis2016227_CR9","first-page":"601361","volume":"2013","author":"HC Chi","year":"2013","unstructured":"Chi HC, Chen CY, Tsai MM, Tsai CY, Lin KH . Molecular functions of thyroid hormones and their clinical significance in liver-related diseases. Biomed Res Int 2013; 2013: 601361.","journal-title":"Biomed Res Int"},{"key":"BFcddis2016227_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/01926230390173851","volume":"31","author":"GM Ledda-Columbano","year":"2003","unstructured":"Ledda-Columbano GM, Perra A, Concas D, Cossu C, Molotzu F, Sartori C et al. Different effects of the liver mitogens triiodo-thyronine and ciprofibrate on the development of rat hepatocellular carcinoma. Toxicol Pathol 2003; 31: 113\u2013120.","journal-title":"Toxicol Pathol"},{"key":"BFcddis2016227_CR11","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1093\/carcin\/20.12.2299","volume":"20","author":"GM Ledda-Columbano","year":"1999","unstructured":"Ledda-Columbano GM, Perra A, Piga R, Pibiri M, Loi R, Shinozuka H et al. Cell proliferation induced by 3,3',5-triiodo-L-thyronine is associated with a reduction in the number of preneoplastic hepatic lesions. Carcinogenesis 1999; 20: 2299\u20132304.","journal-title":"Carcinogenesis"},{"key":"BFcddis2016227_CR12","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1038\/cdd.2012.58","volume":"19","author":"HC Chi","year":"2012","unstructured":"Chi HC, Chen SL, Liao CJ, Liao CH, Tsai MM, Lin YH et al. Thyroid hormone receptors promote metastasis of human hepatoma cells via regulation of TRAIL. Cell Death Differ 2012; 19: 1802\u20131814.","journal-title":"Cell Death Differ"},{"key":"BFcddis2016227_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrm2308","volume":"9","author":"RJ Youle","year":"2008","unstructured":"Youle RJ, Strasser A . The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008; 9: 47\u201359.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFcddis2016227_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nri1568","volume":"5","author":"A Strasser","year":"2005","unstructured":"Strasser A . The role of BH3-only proteins in the immune system. Nat Rev Immunol 2005; 5: 189\u2013200.","journal-title":"Nat Rev Immunol"},{"key":"BFcddis2016227_CR15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2004.12.030","volume":"17","author":"L Chen","year":"2005","unstructured":"Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 2005; 17: 393\u2013403.","journal-title":"Mol Cell"},{"key":"BFcddis2016227_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0014-5793(01)03145-3","volume":"509","author":"M U","year":"2001","unstructured":"U M, Miyashita T, Shikama Y, Tadokoro K, Yamada M . Molecular cloning and characterization of six novel isoforms of human Bim, a member of the proapoptotic Bcl-2 family. FEBS Lett 2001; 509: 135\u2013141.","journal-title":"FEBS Lett"},{"key":"BFcddis2016227_CR17","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/emboj\/17.2.384","volume":"17","author":"L O'Connor","year":"1998","unstructured":"O'Connor L, Strasser A, O'Reilly LA, Hausmann G, Adams JM, Cory S et al. Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J 1998; 17: 384\u2013395.","journal-title":"EMBO J"},{"key":"BFcddis2016227_CR18","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/sj.cdd.4401688","volume":"12","author":"R Ley","year":"2005","unstructured":"Ley R, Ewings KE, Hadfield K, Cook SJ . Regulatory phosphorylation of Bim: sorting out the ERK from the JNK. Cell Death Differ 2005; 12: 1008\u20131014.","journal-title":"Cell Death Differ"},{"key":"BFcddis2016227_CR19","doi-asserted-by":"publisher","first-page":"6050","DOI":"10.1111\/j.1742-4658.2009.07329.x","volume":"276","author":"AS Gillings","year":"2009","unstructured":"Gillings AS, Balmanno K, Wiggins CM, Johnson M, Cook SJ . Apoptosis and autophagy: BIM as a mediator of tumour cell death in response to oncogene-targeted therapeutics. FEBS J 2009; 276: 6050\u20136062.","journal-title":"FEBS J"},{"key":"BFcddis2016227_CR20","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1158\/1535-7163.MCT-09-0685","volume":"8","author":"T Akiyama","year":"2009","unstructured":"Akiyama T, Dass CR, Choong PF . Bim-targeted cancer therapy: a link between drug action and underlying molecular changes. Mol Cancer Ther 2009; 8: 3173\u20133180.","journal-title":"Mol Cancer Ther"},{"key":"BFcddis2016227_CR21","doi-asserted-by":"publisher","first-page":"22384","DOI":"10.1074\/jbc.M111.239566","volume":"286","author":"J Wang","year":"2011","unstructured":"Wang J, Zhou JY, Wu GS . Bim protein degradation contributes to cisplatin resistance. J Biol Chem 2011; 286: 22384\u201322392.","journal-title":"J Biol Chem"},{"key":"BFcddis2016227_CR22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1593\/neo.81358","volume":"11","author":"Y Yang","year":"2009","unstructured":"Yang Y, Zhao Y, Liao W, Yang J, Wu L, Zheng Z et al. Acetylation of FoxO1 activates Bim expression to induce apoptosis in response to histone deacetylase inhibitor depsipeptide treatment. Neoplasia 2009; 11: 313\u2013324.","journal-title":"Neoplasia"},{"key":"BFcddis2016227_CR23","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1083\/jcb.200303026","volume":"162","author":"J Gilley","year":"2003","unstructured":"Gilley J, Coffer PJ, Ham J . FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J Cell Biol 2003; 162: 613\u2013622.","journal-title":"J Cell Biol"},{"key":"BFcddis2016227_CR24","doi-asserted-by":"publisher","first-page":"27907","DOI":"10.1074\/jbc.M104278200","volume":"276","author":"HH Zhao","year":"2001","unstructured":"Zhao HH, Herrera RE, Coronado-Heinsohn E, Yang MC, Ludes-Meyers JH, Seybold-Tilson KJ et al. Forkhead homologue in rhabdomyosarcoma functions as a bifunctional nuclear receptor-interACTINg protein with both coactivator and corepressor functions. J Biol Chem 2001; 276: 27907\u201327912.","journal-title":"J Biol Chem"},{"key":"BFcddis2016227_CR25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0092-8674(04)00452-0","volume":"117","author":"D Accili","year":"2004","unstructured":"Accili D, Arden KC . FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 2004; 117: 421\u2013426.","journal-title":"Cell"},{"key":"BFcddis2016227_CR26","doi-asserted-by":"crossref","first-page":"RE5","DOI":"10.1126\/stke.2003.172.re5","volume":"2003","author":"H Tran","year":"2003","unstructured":"Tran H, Brunet A, Griffith EC, Greenberg ME . The many forks in FOXO's road. Sci STKE 2003; 2003: RE5.","journal-title":"Sci STKE"},{"issue":"Pt 5","key":"BFcddis2016227_CR27","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1042\/BST0340722","volume":"34","author":"EW Lam","year":"2006","unstructured":"Lam EW, Francis RE, Petkovic M . FOXO transcription factors: key regulators of cell fate. Biochem Soc Trans 2006; 34 (Pt 5): 722\u2013726.","journal-title":"Biochem Soc Trans"},{"key":"BFcddis2016227_CR28","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.bbamcr.2011.03.010","volume":"1813","author":"X Zhang","year":"2011","unstructured":"Zhang X, Tang N, Hadden TJ, Rishi AK . Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta 2011; 1813: 1978\u20131986.","journal-title":"Biochim Biophys Acta"},{"key":"BFcddis2016227_CR29","doi-asserted-by":"publisher","first-page":"14104","DOI":"10.1073\/pnas.0601600103","volume":"103","author":"Y Hiroi","year":"2006","unstructured":"Hiroi Y, Kim HH, Ying H, Furuya F, Huang Z, Simoncini T et al. Rapid nongenomic actions of thyroid hormone. Proc Natl Acad Sci USA 2006; 103: 14104\u201314109.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2016227_CR30","doi-asserted-by":"publisher","first-page":"e10365","DOI":"10.1371\/journal.pone.0010365","volume":"5","author":"A Bandyopadhyay","year":"2010","unstructured":"Bandyopadhyay A, Wang L, Agyin J, Tang Y, Lin S, Yeh IT et al. doxorubicin in combination with a small TGFbeta inhibitor: a potential novel therapy for metastatic breast cancer in mouse models. PLoS One 2010; 5: e10365.","journal-title":"PLoS One"},{"key":"BFcddis2016227_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin 2011; 61: 69\u201390.","journal-title":"CA Cancer J Clin"},{"key":"BFcddis2016227_CR32","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1440-1746.2007.05112.x","volume":"23","author":"KW Park","year":"2008","unstructured":"Park KW, Park JW, Choi JI, Kim TH, Kim SH, Park HS et al. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area. J Gastroenterol Hepatol 2008; 23: 467\u2013473.","journal-title":"J Gastroenterol Hepatol"},{"key":"BFcddis2016227_CR33","first-page":"1379","volume":"32","author":"H Cao","year":"2012","unstructured":"Cao H, Phan H, Yang LX . Improved chemotherapy for hepatocellular carcinoma. Anticancer Res 2012; 32: 1379\u20131386.","journal-title":"Anticancer Res"},{"key":"BFcddis2016227_CR34","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/hep.27399","volume":"61","author":"C Frau","year":"2015","unstructured":"Frau C, Loi R, Petrelli A, Perra A, Menegon S, Kowalik MA et al. Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats. Hepatology 2015; 61: 249\u2013259.","journal-title":"Hepatology"},{"key":"BFcddis2016227_CR35","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/hep.22793","volume":"49","author":"MM Hassan","year":"2009","unstructured":"Hassan MM, Kaseb A, Li D, Patt YZ, Vauthey JN, Thomas MB et al. Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States. Hepatology 2009; 49: 1563\u20131570.","journal-title":"Hepatology"},{"key":"BFcddis2016227_CR36","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1053\/j.gastro.2010.01.041","volume":"138","author":"E Kress","year":"2010","unstructured":"Kress E, Skah S, Sirakov M, Nadjar J, Gadot N, Scoazec JY et al. Cooperation between the thyroid hormone receptor TRalpha1 and the WNT pathway in the induction of intestinal tumorigenesis. Gastroenterology 2010; 138: 1863\u20131874.","journal-title":"Gastroenterology"},{"key":"BFcddis2016227_CR37","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1158\/0008-5472.CAN-08-2198","volume":"69","author":"O Martinez-Iglesias","year":"2009","unstructured":"Martinez-Iglesias O, Garcia-Silva S, Tenbaum SP, Regadera J, Larcher F, Paramio JM et al. Thyroid hormone receptor beta1 acts as a potent suppressor of tumor invasiveness and metastasis. Cancer Res 2009; 69: 501\u2013509.","journal-title":"Cancer Res"},{"key":"BFcddis2016227_CR38","first-page":"7415","volume":"50","author":"S Preston-Martin","year":"1990","unstructured":"Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE . Increased cell division as a cause of human cancer. Cancer Res 1990; 50: 7415\u20137421.","journal-title":"Cancer Res"},{"key":"BFcddis2016227_CR39","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/BF01297150","volume":"36","author":"E Farber","year":"1991","unstructured":"Farber E . Hepatocyte proliferation in stepwise development of experimental liver cell cancer. Dig Dis Sci 1991; 36: 973\u2013978.","journal-title":"Dig Dis Sci"},{"key":"BFcddis2016227_CR40","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1096\/fasebj.10.10.8751714","volume":"10","author":"A Columbano","year":"1996","unstructured":"Columbano A, Shinozuka H . Liver regeneration versus direct hyperplasia. FASEB J 1996; 10: 1118\u20131128.","journal-title":"FASEB J"},{"key":"BFcddis2016227_CR41","doi-asserted-by":"publisher","first-page":"8969","DOI":"10.1128\/MCB.20.23.8969-8982.2000","volume":"20","author":"N Nakamura","year":"2000","unstructured":"Nakamura N, Ramaswamy S, Vazquez F, Signoretti S, Loda M, Sellers WR . Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol Cell Biol 2000; 20: 8969\u20138982.","journal-title":"Mol Cell Biol"},{"key":"BFcddis2016227_CR42","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/35008115","volume":"404","author":"RH Medema","year":"2000","unstructured":"Medema RH, Kops GJ, Bos JL, Burgering BM . AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 2000; 404: 782\u2013787.","journal-title":"Nature"},{"key":"BFcddis2016227_CR43","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1126\/science.1068712","volume":"296","author":"H Tran","year":"2002","unstructured":"Tran H, Brunet A, Grenier JM, Datta SR, Fornace AJ Jr., DiStefano PS et al. DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein. Science 2002; 296: 530\u2013534.","journal-title":"Science"},{"key":"BFcddis2016227_CR44","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.canlet.2008.05.029","volume":"272","author":"CD Simpson","year":"2008","unstructured":"Simpson CD, Anyiwe K, Schimmer AD . Anoikis resistance and tumor metastasis. Cancer Lett 2008; 272: 177\u2013185.","journal-title":"Cancer Lett"},{"key":"BFcddis2016227_CR45","doi-asserted-by":"publisher","first-page":"10744","DOI":"10.1158\/0008-5472.CAN-07-3148","volume":"67","author":"NT Woods","year":"2007","unstructured":"Woods NT, Yamaguchi H, Lee FY, Bhalla KN, Wang HG . Anoikis, initiated by Mcl-1 degradation and Bim induction, is deregulated during oncogenesis. Cancer Res 2007; 67: 10744\u201310752.","journal-title":"Cancer Res"},{"key":"BFcddis2016227_CR46","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1158\/1541-7786.MCR-07-0254","volume":"6","author":"N Uehara","year":"2008","unstructured":"Uehara N, Matsuoka Y, Tsubura A . Mesothelin promotes anchorage-independent growth and prevents anoikis via extracellular signal-regulated kinase signaling pathway in human breast cancer cells. Mol Cancer Res 2008; 6: 186\u2013193.","journal-title":"Mol Cancer Res"},{"key":"BFcddis2016227_CR47","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.cardiores.2005.08.009","volume":"69","author":"P Spallarossa","year":"2006","unstructured":"Spallarossa P, Altieri P, Garibaldi S, Ghigliotti G, Barisione C, Manca V et al. Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase. Cardiovasc Res 2006; 69: 736\u2013745.","journal-title":"Cardiovasc Res"},{"key":"BFcddis2016227_CR48","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.mce.2009.04.013","volume":"307","author":"CS Liao","year":"2009","unstructured":"Liao CS, Tai PJ, Huang YH, Chen RN, Wu SM, Kuo LW et al. Regulation of AKR1B1 by thyroid hormone and its receptors. Mol Cell Endocrinol 2009; 307: 109\u2013117.","journal-title":"Mol Cell Endocrinol"},{"key":"BFcddis2016227_CR49","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.3748\/wjg.v10.i21.3107","volume":"10","author":"YS Gao","year":"2004","unstructured":"Gao YS, Chen XP, Li KY, Wu ZD . Nude mice model of human hepatocellular carcinoma via orthotopic implantation of histologically intact tissue. World J Gastroenterol 2004; 10: 3107\u20133111.","journal-title":"World J Gastroenterol"},{"key":"BFcddis2016227_CR50","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.1172\/JCI63428","volume":"123","author":"SC Liu","year":"2013","unstructured":"Liu SC, Tsang NM, Chiang WC, Chang KP, Hsueh C, Liang Y et al. Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance. J Clin Invest 2013; 123: 5269\u20135283.","journal-title":"J Clin Invest"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cddis2016227.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2016227","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2016227.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T09:04:16Z","timestamp":1672823056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2016227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,4]]},"references-count":50,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8]]}},"alternative-id":["BFcddis2016227"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2016.227","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,4]]},"assertion":[{"value":"6 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}